Zacks Research Issues Pessimistic Forecast for MOH Earnings

Key Points

• Zacks Research cut its Q1 2027 EPS forecast for Molina Healthcare to $2.48 from $2.53 and maintains a “Hold” rating.
• Molina beat the latest quarter’s estimates, reporting EPS of $0.89 versus $0.79 expected and revenue of $11.08 billion versus $10.86 billion. However, revenue fell 3.4% year over year, and EPS declined from $1.84 a year earlier.
• Analyst sentiment is broadly neutral: 13 analysts rate the stock “Hold,” three “Buy,” and two “Sell,” with a consensus price target of $213.88.

Molina Healthcare, Inc (NYSE:MOH - Free Report) - Stock analysts at Zacks Research cut their Q1 2027 earnings estimates for shares of Molina Healthcare in a research note issued to investors on Wednesday, November 11th. Zacks Research analyst Team now anticipates that the company will post earnings of $2.48 per share for the quarter, down from their previous estimate of $2.53. Zacks Research has a "Hold" rating on the stock. The consensus estimate for Molina Healthcare's current full-year earnings is $5.30 per share. Zacks Research also issued estimates for Molina Healthcare's Q3 2027 earnings at $2.17 EPS and Q3 2028 earnings at $3.85 EPS.

Molina Healthcare (NYSE:MOH - Get Free Report) last released its earnings results on Wednesday, October 21st. The company reported $0.89 EPS for the quarter, topping the consensus estimate of $0.79 by $0.10. The company had revenue of $11.08 billion during the quarter, compared to analysts' expectations of $10.86 billion. Molina Healthcare had a negative net margin of 0.11% and a positive return on equity of 2.50%. The business's revenue was down 3.4% on a year-over-year basis. During the same quarter last year, the business earned $1.84 EPS.

MOH has been the subject of a number of other reports. Deutsche Bank reissued a "hold" rating and set a $163.00 target price on shares of Molina Healthcare in a research note on Monday, October 26th. Barclays dropped their price objective on Molina Healthcare from $180.00 to $178.00 and set an "underweight" rating on the stock in a report on Friday, October 23rd. Wells Fargo & Company cut their price objective on Molina Healthcare from $235.00 to $220.00 and set an "equal weight" rating for the company in a research report on Tuesday, July 28th. JPMorgan Chase & Co. raised their target price on Molina Healthcare from $220.00 to $225.00 and gave the company a "neutral" rating in a report on Tuesday, October 27th. Finally, Jefferies Financial Group reissued a "hold" rating and issued a $220.00 target price on shares of Molina Healthcare in a report on Friday, October 23rd. Three investment analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $213.88.

Molina Healthcare Price Performance

Shares of MOH opened at $209.65 on Friday. Molina Healthcare has a twelve month low of $121.06 and a twelve month high of $244.89. The stock's 50 day moving average is $202.43 and its two-hundred day moving average is $185.57. The firm has a market capitalization of $10.94 billion, a PE ratio of 104.62, a P/E/G ratio of 12.34 and a beta of 0.75. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.95.

Hedge Funds Weigh In On Molina Healthcare

Several hedge funds have recently bought and sold shares of the company. Fortitude Family Office LLC boosted its position in Molina Healthcare by 63.7% during the third quarter. Fortitude Family Office LLC now owns 131 shares of the company's stock worth $25,000 after purchasing an additional 51 shares in the last quarter. Elevation Wealth Partners LLC grew its holdings in Molina Healthcare by 118.2% in the second quarter. Elevation Wealth Partners LLC now owns 144 shares of the company's stock valued at $33,000 after purchasing an additional 78 shares during the last quarter. Global Retirement Partners LLC purchased a new position in shares of Molina Healthcare in the second quarter valued at $39,000. Versant Capital Management Inc increased its position in shares of Molina Healthcare by 341.6% in the second quarter. Versant Capital Management Inc now owns 340 shares of the company's stock valued at $78,000 after buying an additional 263 shares in the last quarter. Finally, Contravisory Investment Management Inc. purchased a new position in shares of Molina Healthcare in the second quarter valued at $89,000. 98.50% of the stock is owned by hedge funds and other institutional investors.

About Molina Healthcare

Molina Healthcare, Inc. is a managed care company that provides health insurance plans primarily to people covered by government-sponsored programs. Its offerings include Medicaid plans, Medicare plans for eligible individuals and dual-eligible members, and health plans sold through government marketplaces under the Affordable Care Act. The company was founded in 1980 by physician C. David Molina in Long Beach, California, initially serving low-income families through community clinics. It later shifted its focus to providing managed health care, with Medicaid becoming a central part of its business.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.